Paul Peter Tak - Nov 28, 2023 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Executive Officer, Director
Signature
/s/ Jason Amello, as Attorney-in-Fact for Paul Peter Tak
Stock symbol
CADL
Transactions as of
Nov 28, 2023
Transactions value $
-$39,099
Form type
4
Date filed
11/30/2023, 05:00 PM
Previous filing
Nov 28, 2023
Next filing
Jul 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Tax liability -$39.1K -43.4K -10.42% $0.90 374K Nov 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer to satisfy tax withholding obligations associated with the vesting and settlement of restricted stock units.